Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study

BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are considered to have similar renoprotective effects; so far there has been no consensus about their priorities. This study aimed to compare ACEIs and ARBs for major renal outcomes and survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hon-Yen, Peng, Chiao-Ling, Chen, Pei-Chun, Chiang, Chih-Kang, Chang, Chee-Jen, Huang, Jenq-Wen, Peng, Yu-Sen, Tu, Yu-Kang, Chu, Tzong-Shinn, Hung, Kuan-Yu, Chien, Kuo-Liong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432180/
https://www.ncbi.nlm.nih.gov/pubmed/28505194
http://dx.doi.org/10.1371/journal.pone.0177654

Ejemplares similares

Ejemplares similares